Literature DB >> 9450670

Culturing of human vascular endothelial cells strongly affects their endothelin-1 and prostacyclin production.

V Ranta1, A Orpana, T Mikkola, O Ylikorkala, L Viinikka.   

Abstract

Cultured human umbilical vein endothelial cells (HUVECs) are a widely used model to study the regulation of endothelial production of vasoactive substances such as endothelin-1 (ET-1) and prostacyclin (PGI2) in human. As even short term culturing is known to affect the function of many cell types, we studied whether there are differences in the production of ET-1 and PGI2 between freshly isolated HUVECs and HUVECs cultured for two passages, and whether variation in cell density affects the production of ET-1 and PGI2 by these cells. At confluency, freshly isolated HUVECs produced only from one-tenth to one-fifth of ET-1, but 46-86 times more PGI2 (p < 0.001), when compared to respective productions by similar amounts of cultured HUVECs. When the cell density of freshly isolated HUVECs was lowered either by diluting the cell suspension or by plating the same amount of cells on different size wells, the production of ET-1 increased: lowering cell density to one-tenth led to 18 fold increase in ET-1 production (p < 0.001). PGI2 production was not affected by cell density. Thus our data imply that the production of both ET-1 and PGI2 are differently regulated in freshly isolated and cultured HUVECs, and that cell density is an important determinant in the regulation of ET-1 production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9450670     DOI: 10.1023/a:1006842718819

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

1.  Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells.

Authors:  M Yoshizumi; H Kurihara; T Sugiyama; F Takaku; M Yanagisawa; T Masaki; Y Yazaki
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

Review 2.  Hemodynamics and vascular endothelial biology.

Authors:  R M Nerem; D G Harrison; W R Taylor; R W Alexander
Journal:  J Cardiovasc Pharmacol       Date:  1993       Impact factor: 3.105

3.  Modulation of coronary tone in acute myocardial infarction by endothelin.

Authors:  K Salminen; I Tikkanen; O Saijonmaa; M Nieminen; F Fyhrquist; M H Frick
Journal:  Lancet       Date:  1989-09-23       Impact factor: 79.321

4.  Release of prostacyclin, endothelium-derived relaxing factor and endothelin by freshly harvested cells attached to microcarrier beads.

Authors:  S Kibira; R Dudek; K S Narayan; R J Bing
Journal:  Mol Cell Biochem       Date:  1991-11-13       Impact factor: 3.396

5.  Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells.

Authors:  I Komuro; H Kurihara; T Sugiyama; M Yoshizumi; F Takaku; Y Yazaki
Journal:  FEBS Lett       Date:  1988-10-10       Impact factor: 4.124

6.  The endothelin system. A new target for therapeutic intervention.

Authors:  M Yanagisawa
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

7.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Fluorometric quantification of DNA in cells and tissue.

Authors:  T R Downs; W W Wilfinger
Journal:  Anal Biochem       Date:  1983-06       Impact factor: 3.365

9.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Authors:  D A Scudiero; R H Shoemaker; K D Paull; A Monks; S Tierney; T H Nofziger; M J Currens; D Seniff; M R Boyd
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

10.  17 beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells.

Authors:  T Mikkola; P Turunen; K Avela; A Orpana; L Viinikka; O Ylikorkala
Journal:  J Clin Endocrinol Metab       Date:  1995-06       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.